My tirzepatide stalled with PCOS: is my state covered?

Your tirzepatide stalled with PCOS, and you did what you were supposed to do: you reported it. The telehealth service that prescribes it answered with a higher dose. When the scale held still again, it answered with the next one. Nobody ordered a lab. Nobody asked what else had changed in your life, or whether your cycle, your sleep or your other medications had moved. Nobody told you why a medication that worked for months might stop working for you, because nobody had tried to find out.

Now you are looking at a different kind of care, and the first practical question is a small one: does it reach the state you live in? It does. GoodLife Health has clinicians licensed in all fifty states. But the state question is the easy one, and this piece is written for the harder one underneath it, which is whether this membership is right for you at all. Many people should not buy it. If you are one of them, you should find that out here, before you reach a checkout page.

Where you are: a stall, a bigger number and no reason

The first months probably went the way the advertising suggested. The weight moved, your clothes fit differently, and for a while it felt as though something had finally worked. Then the progress stopped, and it stayed stopped long enough that you knew it was more than a bad week.

You sent a message through the portal. The reply came from whoever was working the queue that day, and it was a new prescription at a higher dose, with an instruction to check back in a few weeks. There was no lab order attached and no question about the condition written on your intake form. The second time it happened, the reply was the same, one step further up.

A higher dose is sometimes the right decision. A clinician who has looked carefully at your situation may well arrive there, and if one does, you will hear why. What you are reacting to, reasonably, is that nobody looked. You have PCOS. You have probably explained it to more than one doctor over the years, and you mentioned it when you signed up. After the intake form, it never came up again. Every conversation since has been about one number on a prescription label.

That leaves you somewhere uncomfortable. You are paying for a medication, you are tolerating whatever the higher doses bring, and you do not know whether the plan is working, stalled for a reason that could be found, or simply the wrong plan. You have started to look around. At one end of the market sits the $20,000-a-year concierge practice, where someone will sit with you for an hour. At the other sits the $99-a-month compounded app, built on a form, a queue and a refill. Whatever your current service charges, the care you describe belongs to that second model.

GoodLife Health sits between the two and says so plainly (the guide to what GoodLife Health is covers the model in full). Before any of that is worth reading, though, you want to know whether it is even available where you live, because there is no point going further if the answer is no.

What is really going on: two questions, and the one under both

"Is my state covered?" usually means one of two things, and they have different answers. It helps to separate them, because one of them is GoodLife Health's to answer and the other is not.

The first meaning is whether a clinician can legally care for you where you live. Here the answer is yes, everywhere in the country: GoodLife Health's clinicians are licensed in all fifty states. They practice independently in Arizona and California, with collaborating physicians elsewhere, and that arrangement is how one practice can care for patients from Arizona to Maine. There is one membership at one price, and it is offered in all fifty states. Where you live decides which pharmacies are near you and which lab location you will visit. It does not decide whether you can be a member.

The second meaning is whether your medication will be covered, which is a question about insurance. That one belongs to you, your plan and your pharmacy. If your plan requires prior authorization for tirzepatide, that is the pharmacy's process; GoodLife Health does not run it, speed it up or win it. Nobody here can promise you coverage, and you should be careful with anyone who does before your plan has given its own answer.

With the state question settled, the real one is left: why did nobody try to find out what was happening to you?

Part of the answer may be structural. A platform that earns its money on the drug has a structural incentive to keep you on the highest tolerable dose. We do not know how your current service is paid, and we are not going to guess about a company we have not named. It is still a fair question to put to any prescriber, including this one: when the only lever anyone pulls is the dose, what does the business behind that lever earn when it moves?

The larger part is the order in which care happens. Care that starts with a prescription has nothing to measure the prescription against. When the results stop coming, the only tool on the table is the prescription itself, so the dose goes up. Care that starts with a diagnosis has a baseline: labs drawn before a decision is made, and labs drawn again afterward, so a clinician can see whether the plan is doing what it was meant to do. Follow-up labs are the only way to confirm a protocol is working. A form and a refill queue cannot tell you that.

Your PCOS makes the case for looking stronger. You are asking one medication to work inside a condition that, in your experience so far, no one managing the medication has asked about. A clinician who has your numbers in front of them can at least talk with you about the whole of it.

None of this means that a blood draw will reveal a single hidden cause, and no honest clinician will tell you it will. What it means is that the next decision gets made by someone who has seen your results and can explain them. That decision might be a higher dose. It might be the same dose with a different plan around it, a different medication, or something you had not considered. Whatever it is, you will know the reasoning, and you will have a date when the labs will show whether it was right.

What the membership does, what it costs, and what it does not do

GoodLife Health is precision direct primary care for Cardiometabolic Optimization: diagnosis first, then treatment, then the long haul. It is clinician-led and labs-first, which in practice means the relationship begins with measurement rather than with a prescription.

The membership includes four cardiometabolic lab panels a year, one every quarter, which we call the Biomarker Audit. The panel includes a metabolic panel, a lipid panel, HbA1c, a hormone panel, TSH, fasting insulin and a CBC, drawn at a local LabCorp or Quest location. Every result is in your hands. The clinician reviews the results with you, explains what each marker means and how it connects to what you have been living with, and then builds a plan.

Between panels you have asynchronous messaging with the care team and video visits. In direct primary care, as this walk-through of what a direct primary care visit actually looks like describes, a first visit typically runs 45 to 60 minutes and ends with a protocol: what to do now, what to recheck and when, and what to message about if something changes. If the scale holds still again, you can message about it, and the reply can draw on the quarterly numbers in your chart.

If a clinician judges that medication is indicated, it is prescribed to the pharmacy you choose, at that pharmacy's own price. GoodLife Health prescribes branded, FDA-approved medication only; for tirzepatide, that means Zepbound or Mounjaro. Under Medication-Neutral Pricing, the fee is the same whatever medication is indicated and whatever the dose, with no molecule upcharge and no dose upcharge. GoodLife Health sets nothing, sees nothing and takes nothing on medication. A decision to raise your dose, hold it or change course earns the practice nothing either way, which is the reason it is built like this.

For a reference point on the medication itself, Lilly's own self-pay prices through LillyDirect, as published in September 2026, put Zepbound vials at $299 to $449 a month depending on dose. What you would actually pay depends on your pharmacy, your plan and the dose a clinician prescribes, and whether insurance covers any of it is never promised.

If what you take now is compounded tirzepatide, you should know before going further that GoodLife Health never prescribes compounded GLP-1. That is a decision about the model, and it says nothing about you. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, the manufacturers have taken legal action over compounded copies, and the clinician who writes any prescription carries the responsibility for it under their license. If moving to branded medication at a pharmacy's price would put care out of reach, that is a real reason to stop here, and it is better to know now.

The membership itself is $299 a month, month to month. At sign-up, $598 is charged, covering the first two months. Over a full year the membership is $3,588. The fee is generally eligible for HSA or FSA pre-tax dollars. It pairs with your insurance for catastrophic coverage and does not replace it. What it replaces is the primary-care relationship, the one that should have asked about your PCOS long before anyone raised a dose.

Not everyone is accepted. The path is the eligibility check, the intake, the checkout, then a clinician's review. If the clinician cannot accept you into care, the $598 is refunded in full. Once you are accepted, the first two months are non-refundable, and any medication billed by a pharmacy follows that pharmacy's own return and refund policy.

What the membership does not do matters as much as what it does. It does not promise that you will start losing weight again, or lose any particular amount. It does not promise a specific medication or a specific dose. It does not promise that your plan will cover tirzepatide or that a prior authorization will be approved. What it offers is a clinician who looks before deciding, and quarterly labs to look at.

So, is your state covered? The honest answer

Yes, if you live in any of the fifty states. That was never going to be the hard part.

The hard part is deciding whether you want what this membership is, because at the start it is slower than the service you have now. There is an eligibility check, an intake, a checkout, labs and a clinician's review before anything is prescribed or changed. If you wanted a faster refill, all of that will feel like friction. If you wanted someone to tell you why the medication stopped working, the friction is where that answer comes from.

It is also worth being clear about what you would be paying for. You would be paying for time and attention from a clinician, and for the labs that make the attention worth something. You would not be paying for a better price on tirzepatide, because GoodLife Health has no hand in what the pharmacy charges.

Who this is not for

This membership is the wrong purchase for a good number of people, and some of them are reading this article. It is better that you leave now than after a checkout you regret.

If you want the next dose and nothing else, and you are content with how your current service handles it, stay where you are. A clinician here might raise your dose too, but only after looking, and you would be paying $299 a month for the looking.

If your budget is built around a $99-a-month compounded app, and the price is why you chose it, this will not fit. The membership costs $299 a month before any medication, the medication is branded and billed by your pharmacy at its own price, and compounded GLP-1 is not available here at any price. Pretending the numbers are close would do you no favors.

If you need a guarantee, whether of a number on the scale, of insurance coverage or of an approved prior authorization, nobody here will give you one.

If you are hoping the membership will replace your health insurance, it will not. You still need coverage for everything a primary-care relationship cannot handle.

If you are not willing to have your labs drawn each quarter, the clinician has nothing to work with, and the membership loses most of its value to you.

And if you do not live in one of the fifty states, the licenses that make this work do not reach you.

If none of that describes you, and what you want is a clinician who will read your numbers alongside the medication you have been taking, the next step costs nothing. The eligibility check takes about five minutes, and there is no charge until you confirm membership.

Related Reading

• What Is GoodLife Health? Direct Primary Care, Explained (2026)
• What a Direct Primary Care Visit Actually Looks Like (2026)

References

1. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
2. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss